Company Information
CIN
Status
Date of Incorporation
23 August 1947
State / ROC
Mumbai / ROC Mumbai
Last Balance Sheet
31 March 2023
Last Annual Meeting
26 September 2023
Paid Up Capital
184,300,710
Authorised Capital
250,000,000
Directors
Madhura Suresh Kare
Director/Designated Partner
over 2 years ago
over 2 years ago
Aruna Suresh Kare
Director/Designated Partner
over 2 years ago
over 2 years ago
Suresh Govind Kare
Director/Designated Partner
over 2 years ago
over 2 years ago
Sundeep Vasant Bambolkar
Director/Designated Partner
over 3 years ago
over 3 years ago
Pramod Ramchandra Ghorpade
Manager/Secretary
about 4 years ago
about 4 years ago
Abhijit Yashawant Gore
Director/Designated Partner
about 5 years ago
about 5 years ago
Jayshankar Menon
Company Secretary
over 8 years ago
over 8 years ago
Anand Madhusudan Nadkarni
Director/Designated Partner
over 11 years ago
over 11 years ago
Aditi Milind Panandikar
Director/Designated Partner
almost 14 years ago
almost 14 years ago
Rajiv Pritidas Kakodkar
Director/Designated Partner
almost 18 years ago
almost 18 years ago
Divakar Madhusudan Gavaskar
Director/Designated Partner
over 20 years ago
over 20 years ago
Past Directors
Vasudha Vasant Kamat
Additional Director
over 5 years ago
over 5 years ago
Anil Mahadeo Naik
Director
over 13 years ago
over 13 years ago
Sunil Dattatraya Joshi
Company Secretary
almost 14 years ago
almost 14 years ago
Sharad Pandurang Upasani
Director
about 16 years ago
about 16 years ago
Atul Sakharam Rajadhyaksha
Director
almost 18 years ago
almost 18 years ago
Anil Bhalchandra Kale
Company Secretary
about 20 years ago
about 20 years ago
Francis Xavier Coutinho
Director
over 21 years ago
over 21 years ago
Dattatraya Mahadeo Sukthankar
Director
about 31 years ago
about 31 years ago
Madhukar Narvekar
Director
over 48 years ago
over 48 years ago
Patents
Disclosed here is a process for the preparation of nitropyridine derivatives of Formula I and its salt and precursors such as halogenated amino pyridines;
Formula-I Wherein;
R1 is selected from amino group, hydroxyl group, acyl group, alkyl amino group, halogen atom, -NH-C(O)-R3;
Where R3 is branched or linear...
A Process for the Preparation of Pharmaceutical Composition of Apixaban. The present invention relates to a process for the preparation of pharmaceutical composition comprising Apixaban, the pharmaceutical composition resulting from this process and its use for the prophylaxis and/or treatment of a thromboembolic di...
The present invention relates to a novel organogel composition for Orobuccal drug delivery. The present invention is directed to provide an organogel system suitable for orobuccal drug delivery using cellulose which readily gels in organic solvent.
The present invention discloses an improved process for the preparation of moxifloxacin hydrochloride of formula I.
Disclosed herein is an improved process for the preparation of 7-[(3R)-3-aminohexahydro-1H-azepin-1 -yl]-8-chloro-1 -cyclopropyl-6-fluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid of formula -1 and its pharmaceutically acceptable salt.
The present invention discloses one pot process for the preparation of intermediate 1-C-alkyl hexopyranose compound of Formula I useful in the preparation of Valienamine, Valiolamine and their N-substituted derivative.
Formula I wherein R is halo group selected from chlorine, bromine & iodine; and R1 is hydroxyl...
Disclosed herein is a process for the preparation of (R)-N-propargyl-l-aminoindane of Formula - I and its pharmaceutically acceptable salt; .comprising a step of reacting (R) -1 -aminoindane of Formula - II with propargyl derivative of Formula - III
wherein x = CI, Br and - ORj; and Rj = mesyl, tosyl, p - methox...
The preseht ihvehtioh discloses a hovel process for the preparatioh of
heostigmihe methylsulfate reactihg the compouhd 3—(dimethylamiho)phehol with
_dimethylcarbamic halide ih presehce of base, phase trahsfer catalyst ahd solveht
to obtaih ah ihtermediate compouhd 3-(dimethylamih6)phehyl
dimethylcarbamate. The i...
The present invention provides a low volume, high dose injectable preparation of Diclofenac and/or its pharmaceutically acceptable salts, Macrogol 15 Hydroxystearate as a solubilizer, including other pharmaceutically acceptable excipients with water as a principal solvent and a method of preparing the same.
...
The present invention relates to a Coated Olanzapine Formulation. The present invention relates to a stable formulation of Olanzapine tablets coated with Pullulan gum, starch based coating systems, vinylpyrrolidone-vinyl acetate copolymers or combinations thereof to overcome problem of degradation and discoloration....
The present invention discloses novel process for the preparation of (2R)-2-acetamido-N-benzyl-3-methoxypropanamide of Formula I involving novel intermediates of Formula -XIX and Formula-XX.
Disclosed herein a process for the preparation of compound 4-amino-1-isobutyI-lH-imidazo[4,5-c] quinoline [Imiquimod] of Formula I;
Disclosed herein is a process for preparation of 2-(3-cyaflo-4-isobutoxyphenyl)-4-methyl-5-thiazolecarboxylic acid of Formula-I comprising Oalkylating the compound ethyl 2-(3-cyano-4-hydroxyphenyI)-4-methyl-thiazole-5-carboxylate of Formula-IX with 2-methyl halo propane of Formula-X followed by hydrolyzing the inter...
The present invention relates to a novel pharmaceutical composition of Linezolid. The present invention relates to a novel pharmaceutical composition comprising linezolid Form III along with pharmaceutically acceptable excipients and a process to prepare the said composition. The present invention relates to an oral...
Disclosed herein is an improved process for the preparation of 3-[(2R,3R)-l-(dimethylamino)-2-methylpentan-3-yl] phenol of Formula - I and its pharmaceutically acceptable salt which comprises the reaction of (S)-l-(dimethylamino)-2-methyIpentan-3-one of formula VIII with 3 - bromo anisole of formula II under Grignar...
The present invention relates to a stable aqueous suspension of Loteprednol etabonate. The present invention relates to an aqueous suspension of Loteprednol etabonate using acetate buffer system. The present invention relates to a method of preparing a stable aqueous suspension of Loteprednol etabonate.
...
A Stable Pharmaceutical Composition. The present invention relates to a stable pharmaceutical composition comprising Leucine, Pyridoxine (Vitamin B6) or Pyridoxal 5 phosphate and pharmaceutically acceptable excipients.
The present invention also relates to a method of administering such composition to enhance weigh...
The present invention discloses a process for the preparation of 1 -["(2,6-difluorophenyl)methyl]-lH-l,2,3-triazole-4-carboxamide of Formula 1,
Formula I comprising regioselective cycloaddition of 2,6-difluorobenzyl halide of Formula II, wherein X is chloride, bromide or iodide;
Formula I! with a c...
The present invention relates to a process for manufacturing sterile Brinzolamide Ophthalmic Suspension. Specifically, the present invention relates to a process for manufacturing sterile ophthalmic suspension comprising Brinzolamide sterilized by Dry Heat Sterilization and pharmaceutical suspension obtained by usin...
Disclosed herein is a process for the preparation of the compound 3-[(2R,3R)-l-(dimethylamino)-2-methylpentan-3-yl]phenol comprising a) reacting compound (2S,3R)-l-(dimethylamino)-3-(3-methoxyphenyl)-2-methylpentan-3-ol with a mixture of methanesulfonic acid and dimethyl sulfide to get the compound (2R)-3-(3-hydroxy...
An improved process for the preparation of (S)-3,4-dihydro-6- chloro-4-hydroxy-2-(3-
methoxypropyl)-4H-thieno[3,2-e]-1,2-thiazine ],I -dioxide of Formula-I is disclosed.
A sustained release oral dosage form comprising of gliclazide or its pharmaceutically acceptable salts, water swellable polymer, buffering agent and one or more pharmaceutically acceptable excipients without any soluble saccharide, sugar or polyol
Disclosed herein is a novel stable pharmaceutical composition by administering the combination therapy comprising combination of lornoxicam, paracetamol, serratiopeptidase which can be used for the treatment of acute painful and inflammatory conditions associated with musculoskeletal and dental problems in mammals.
...
Disclosed here is a process for preparation of compound 11 - (Z) - [3 - (Dimethylamino) propylidene] -6, 11 - dihydrodibenz [b, e] oxepin -2 - yl - acetic acid (Olopatadine) and its pharmaceutically acceptable salt comprising reacting compound of Formula - XII Formula-XII where R1 & R2 independently represent H, or ...
The invention encompasses stable oral pharmaceutical comprising candesartan cilexetil and a stabilizing agent like polyethylene glycol 100-400 or light liquid paraffin. Particularly, the present invention relates to the stable oral pharmaceutical comprising candesartan cilexetil and polyethylene glycol 100-400 or li...
Disclosed herein is a process for preparation of 11 - (Z) - [(3 -Dimethylamino) propylidene] - 6, 11 – dihydrodibenz [b,e] oxepin - 2 - acetic acid (Olopatadine) and its pharmaceutical acceptable salts; comprising reacting carboxylic acid protected 11 – oxo – 6, 11 – Dihydrodibenz [b,e] oxepin – 2 – acetic acid with...
Disclosed herein is an efficient environment friendly process for racemisation of enantiomerically enriched 3 - carbamoyl methyl - 5 - methylhexanoic acid, an important intermediate used for the preparation of (S) - 3 - (amifiomethyl) - 5 - methylhexanoic acid.
The present invention relates to process for the preparation of ethyl 6 - [2 - (4, 4 -dimethylthiochroman - 6 - yl) ethynyl] nicotinate and its pharmaceutical acceptable salt.
The invention relates to a novel single step process for the preparation of tablet dosage form. In particular, the invention relates to a novel process for the preparation of tablet dosage form which is cost effective, trounces the problems of hydrophobicity of lubricants like magnesium stearate and obviates the nee...
The present invention relates to an improved process for the preparation of N- {2-[4-(aminosulfonyl) phenyl] ethyl} –3ethyl-4-methyl-2oxo-2, 5-dihydro-1H-pyrrole-1-carboxamide. This compound is useful as a key intermediate in the synthetic preparation of trans-3-Ethyl-2, 5-dihydro-4-methyl-N- [2- [4- [[[[(4-methyl c...
Disclosed here is a process for the preparation of 3 - amino pyrazole derivative of Formula -1
Formula -1 Where R1 = H, C1 - C4 alkyl group or benzyl group or phenyl group; R2 = C1 - C6 alkyl group or benzyl group; comprising a step of reacting the compound of Formula - III, with hydrazine hydrate
Formula - III....
The present invention describes an improved method for the preparation of l-[4-{2-(cyclopropylmethoxy)ethyl}phenoxy]-3-[(l-methylethyl)amino]-2-propanol of Formula-I and its pharmaceutically acceptable salt, which comprises reacting 4 - [ 2 -(Cyclopropylmethoxy) ethyl] phenol with epichlorohydrin in presence of mild...
The present invention discloses novel pharmaceutical compositions comprising morphine or its analogs, lactulose and other suitable pharmaceutical excipients in effective amounts for reducing the side effects associated with use of morphine and its analogs during cough. The present invention further discloses a metho...
The present invention discloses a novel, stable aqueous pharmaceutical injectable composition of Diclofenac sodium in benzyl alcohol as a lone excipient, which is devoid of side effects. The invention further discloses process for preparation of a stable pharmaceutical composition of diclofenac sodium by a simple, c...
Disclosed herein is a process for the preparation of substituted derivatives of 3 - Benzoyl - 2 - amino phenylacetic acid of Formula - I and its pharmaceutically acceptable salts; which comprises the (i) protection of compound 2 - nitro benzophenone of Formula - XV to get the compound of Formula - XVI;(ii) reaction ...
Disclosed herein is a novel process for the preparation of 2-[3-cyano-4-(2-methylpropoxy)phenyl]-4-methylthiazole-5-carboxylic acid and novel intermediates thereof.
The present invention discloses novel pharmaceutical combination compositions comprising ranitidine, lactulose and other suitable pharmaceutical excipients in effective amounts useful for the treatment of constipation as well as acid-related gastrointestinal disorders. The present invention further discloses a metho...
Disclosed herein is stable pharmaceutical composition of olopatadine which comprises, gamma irradiated polyvinyl pyrrolidone and other pharmaceutical ly acceptable excipients.
24 NOV 2008"
14
A pharmaceutical composition providing controlled delivery of methylcobalamin designed to improve the bioavailability of the drug in the upper gastrointestinal tract is described. The pharmaceutical composition is formulated into a tablet dosage form. The pharmaceutical composition comprises of a drug, a gas generat...
Disclosed herein is a process for preparation of endo-(±)-α-hydroxybenzeneacetic acid 8-methyl-8-azabicyclo[3.2.1]oct-3-yl ester [Homatropine] of formula I and its pharmaceutically acceptable salt which comprises reaction of tropine with an ester of phenyl glyoxalic acid to obtain tropine phenyl glyoxalate or its ac...
The invention discloses an efficient process for purification of crude Bosentan of Formula I which selectively removes the bis-sulfonamide (Formula III) impurity to less than 0.05% to undetectable limit and deshydroxyethyl bosentan (Formula IV) impurity to less than 0.1% to obtain substantially pure compound Bosenta...
The present invention discloses novel sustained release dosage forms of quetiapine or its pharmaceutical acceptable salt. Further, the present invention relates to a method for preparing the sustained release pharmaceutical tablet composition which is simple, convenient, and economical to manufacture.
...
The present invention discloses a novel process for the preparation of Dapagliflozin (S)-propylene glycol hydrate of Formula II.
Formula II
The present invention relates to a process for the purification of vildagliptin comprising the formation of vildagliptin-saccharin adduct of formula III.
The present invention relates to a process for the preparation of Anagliptin, the compound of formula I and its novel intermediates.
The present invention relates to a novel process for preparation of 7-[(3R)-3-aminohexahydro-1H-azepin-1 -yl] -8-chloro-1 -cyclopropyl-6-fluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid hydrochloride (besifloxacin hydrochloride) of formula - I using novel intermediate compounds of formula - II...
The present invention relates to a stable ophthalmic gel forming solution comprising Lidocaine & other pharmaceutical excipients. The present invention also relates to an ophthalmic gel forming solution comprising of low concentration of preservative. The gel forming solution on contact with tear fluid transforms in...
The present invention discloses a novel process for the preparation of alogliptin and its pharmaceutically acceptable salt.
The present invention relates to a Stabilization of Prostaglandins. The present invention relates to method of increasing the stability of pharmaceutical composition comprising prostaglandin and pharmaceutically acceptable excipients wherein the method comprises of providing composition in polyethylene conta...
The present invention relates to a stable gel forming solution. More particularly, the present invention relates to a stable solution comprising Timolol, which forms gel on contact with tear fluid. The invention further relates to process for preparation of stable gel forming solution. The present invention ...
The present invention relates to an improved process for the preparation of dorzolamide hydrochloride the compound of Formula I.
The present invention relates to an improved process for purification of posaconazole of Formula I and a novel polymorph thereof.
The present invention discloses an improved process for the preparation of Brexpiprazole and its pharmaceutically acceptable salt. The present invention further discloses a process for purification of Brexpiprazole to reduce or eliminate all known and unknown impurities.
The present invention relates to an improved process for the preparation of empagliflozin of Formula I and its novel intermediates.
The present invention relates to novel pharmaceutical^ acceptable salts of sitagliptin of Formula I, their polymorphs and process for preparation thereof.
Abstract
A Stable Ophthalmic Composition. The present invention relates to a stable ophthalmic composition. Specifically, the present invention relates to a travoprost ophthalmic composition and a method of preparing same, which is chemically stable at room temperature, compatible to the low-density polyethylene (L...
The present invention relates to a stable ophthalmic composition of posaconazole
and method of preparing same, which is chemically stable at room temperature. The
composition of the present invention is a stable and sterile aqueous ophthalmic
composition.
Specifically, the present invention relates to an ophthal...
The present invention discloses to a process for the preparation of brexpiprazole and its pharmaceutically acceptable salt.
The present invention further discloses novel intermediates and process for the preparation of the novel intermediates of brexpiprazole. The invention also discloses a process for purification...
The present invention relates to a process for the preparation of the compound ethyl trans-2-(4-aminocyclohexyl)acetate and its salt of Formula I;
Abstract
A stable spill resistant syrup
The present invention relates to a stable spill resistant syrup comprising of combination of acetaminophen, chlorpheniramine maleate, phenylephrine and other pharmaceutical excipients. The present invention also relates to taste masked spill resistant syrup which is stable a...
A Stable Ophthalmic Composition of Miconazole
The present invention relates to miconazole ophthalmic composition and a method of preparing same, which is chemically stable at room temperature. The composition of the present invention is stable and sterile aqueous ophthalmic composition. Specifically, the present in...
The present invention discloses a novel process for the preparation of (S)-3-amino-2-(4-methylphenyl)propanoic
acid and novel intermediates thereof. The present invention further discloses preparation of novel intermediates during the preparation of (S)-3-amino-2-(4-methylphenyl)propanoic acid.
...
The invention relates to a process for the purification of crude rivaroxaban the compound of formula -I.
40
ABSTRACT
5
ORAL COMPOSITION CONTAINING NARINGIN AND USES THEREOF
The present invention relates to an oral composition comprising an effective amount of
naringin, Zingiber officinale extract, and one or more other actives along with
10 pharmaceutically acceptable excipients; and a process for its preparation...
A Stable Ophthalmic Nanosuspension of Brinzolamide.
The present invention relates to a stable ophthalmic nanosuspension of brinzolamide and a method of preparing same, which is chemically stable at room temperature and free of quaternary ammonium salt. Moreover, the composition of present invention is sterile aqueo...
The present invention relates to a process for preparation of succinylcholine chloride dihydrate of formula 1.
The present invention relates to a process for the preparation of sitagliptin hydrochloride and its polymorph sitagliptin hydrochloride monohydrate of Formula la thereof.
The present invention relates to a stable injectable composition of Triamcinolone acetonide and a method of preparing same, which is stable at controlled room temperature between 20°C- 25°C and packaged in glass material. Specifically, the triamcinolone acetonide injection of the present invention shows improved vis...
The present invention covers a stable oral dosage form of Lofexidine with improved content uniformity. The present invention also provides a composition and manufacturing process to prepare a stable Lofexidine dosage form, along with physical properties and stability data for the final product. The present invention...
The present invention relates to novel polymorphic form III of glimepiride of formula I and process for preparing the same.
Registered Trademarks
[Class : 3] Toothpaste Included In Class 3.
[Class : 5] Medicinal Drugs, Preparation And Device Including Pregnancy Test Kit
[Class : 5] Medicinal And Pharmaceutical Drugs And Preparations
View +275 more Brands for Indoco Remedies Limited.
Charges
24 May 2019
The Saraswat Co-operative Bank Ltd
38 Crore
30 November 2018
Standard Chartered Bank
42 Crore
14 December 2017
The Saraswat Co-operative Bank Ltd
50 Crore
28 December 2016
St Helen's Nominees India Private Limited
53 Crore
19 December 2016
Saraswat Coop Bank Limited
35 Crore
16 September 2016
Citi Bank N.a.
50 Crore
14 July 2015
Citi Bank N.a.
60 Crore
04 January 2010
Citibank N. A.
10 Crore
17 July 2009
Standard Chartered Bank
10 Crore
13 March 2009
Idbi Bank Limited
14 Crore
30 January 2009
State Bank Of India
13 Crore
28 November 2008
The Saraswat Cooperative Bank Ltd
6 Crore
28 November 2008
The Saraswat Cooperative Bank Ltd
75 Lak
28 November 2008
Saraswat Coop Bank Limited
15 Crore
31 July 2008
Members Secretary Himachal Pradesh
30 Lak
10 July 2008
Hdfc Bank Limited
15 Crore
30 June 2008
Kotak Mahindra Bank Limited
25 Crore
06 May 1982
Canara Bank
1 Lak
10 February 1981
Canara Bank
5 Lak
31 March 1979
The Mahrashrtra State Financial Corporation
4 Lak
29 May 2012
Dbs Bank Limited
23 Crore
16 July 2014
The Saraswat Cooperative Bank Ltd
10 Crore
10 February 2014
Idbi Bank Limited
4 Crore
17 January 2011
Dbs Bank Ltd
20 Crore
11 May 2012
Janakalyan Sahakari Bank Limited
4 Crore
23 November 2009
Standard Chartered Bank
28 Crore
23 January 2009
Citi Bank N.a.
15 Crore
27 August 2009
Standard Chartered Bank
24 Crore
17 March 2006
Yes Bank Limited
18 Crore
10 September 1999
State Bank Of India
4 Crore
26 August 2003
State Bank Of India
7 Crore
19 September 1986
The Saraswat Co - Op. Bank Ltd.
6 Lak
28 May 1980
The Saraswat Co - Op Bank Ltd.
18 Lak
12 October 1965
The Saraswat Co - Op. Bank Ltd.
50 Thousand
01 March 1997
The Saraswat Co - Op Bank Ltd.
10 Crore
01 March 1997
The Saraswat Co - Op. Bank Ltd.
10 Crore
27 September 1971
The Saraswat Co - Op Bank Ltd.
50 Thousand
26 July 2001
Export - Import Bank Of India
7 Crore
31 July 2008
Director Of Industries Himachal Pradesh Through General Manager District Industries
30 Lak
27 August 1994
The Saraswat Co - Op Bank Ltd.
35 Lak
16 August 1973
The Saraswat Co - Op Bank Ltd.
2 Lak
18 December 1993
The Saraswat Co - Op Bank Ltd.
1 Crore
14 March 2000
The Saraswat Co - Op Bank Ltd.
13 Crore
17 December 1993
The Saraswat Co - Op Bank Ltd.
28 Lak
14 November 1994
The Saraswat Co - Op Bank Ltd.
22 Lak
27 February 1989
The Saraswat Co - Op Bank Ltd.
29 Lak
23 May 1980
The Saraswat Co - Op Bank Ltd.
18 Lak
01 March 1997
The Saraswat Co-op Bank Ltd.
45 Crore
04 October 1997
The Saraswat Co - Op Bank Ltd.
50 Lak
26 May 1964
The Saraswat Co - Op Bank Ltd.
30 Thousand
14 February 1996
The Saraswat Co - Op Bank Ltd.
20 Lak
07 November 1960
The Saraswat Co - Op Bank Ltd.
25 Thousand
17 July 1967
The Saraswat Co - Op Bank Ltd.
75 Thousand
29 June 1995
The Saraswat Co - Op Bank Ltd.
2 Crore
04 April 1991
The Saraswat Co - Op Bank Ltd.
3 Lak
31 July 1997
The Saraswat Co - Op Bank Ltd.
10 Lak
15 October 1998
The Saraswat Co - Op Bank Ltd.
75 Lak
22 October 1965
The Saraswat Co - Op Bank Ltd.
50 Thousand
27 October 2005
Bank Of India Limited
10 Crore
15 June 2004
Icici Bank Uk Ltd.
25 Lak
10 May 2000
The Saraswat Co - Op. Bank Ltd.
3 Crore
14 June 2001
The Saraswat Co - Op. Bank Ltd.
1 Crore
19 April 1999
The Saraswat Co - Op. Bank Ltd.
5 Crore
10 September 1999
State Bank Of India
4 Crore
23 February 1984
The Saraswat Co - Op Bank Ltd.
14 Lak
26 June 1982
The Saraswat Co - Op Bank Ltd.
2 Lak
24 May 1963
The Saraswat Co - Op Bank Ltd.
30 Thousand
16 August 2023
Hdfc Bank Limited
0
06 January 2023
Others
0
30 May 2022
Hdfc Bank Limited
0
22 March 2022
Others
0
16 September 2016
Citi Bank N.a.
0
05 November 2020
Others
0
14 July 2015
Citi Bank N.a.
0
20 August 2021
Others
0
28 December 2016
Others
0
30 November 2018
Standard Chartered Bank
0
24 May 2019
Others
0
20 December 2019
Standard Chartered Bank
0
20 December 2019
Standard Chartered Bank
0
28 November 2008
Others
0
30 June 2008
Others
0
22 October 1965
The Saraswat Co - Op Bank Ltd.
0
07 November 1960
The Saraswat Co - Op Bank Ltd.
0
24 May 1963
The Saraswat Co - Op Bank Ltd.
0
26 May 1964
The Saraswat Co - Op Bank Ltd.
0
17 July 1967
The Saraswat Co - Op Bank Ltd.
0
27 September 1971
The Saraswat Co - Op Bank Ltd.
0
23 May 1980
The Saraswat Co - Op Bank Ltd.
0
28 May 1980
The Saraswat Co - Op Bank Ltd.
0
26 June 1982
The Saraswat Co - Op Bank Ltd.
0
04 April 1991
The Saraswat Co - Op Bank Ltd.
0
14 February 1996
The Saraswat Co - Op Bank Ltd.
0
31 July 1997
The Saraswat Co - Op Bank Ltd.
0
15 October 1998
The Saraswat Co - Op Bank Ltd.
0
10 May 2000
The Saraswat Co - Op. Bank Ltd.
0
26 August 2003
State Bank Of India
0
04 October 1997
The Saraswat Co - Op Bank Ltd.
0
01 March 1997
The Saraswat Co - Op. Bank Ltd.
0
29 June 1995
The Saraswat Co - Op Bank Ltd.
0
01 March 1997
The Saraswat Co-op Bank Ltd.
0
17 March 2006
Yes Bank Limited
0
27 October 2005
Bank Of India Limited
0
14 June 2001
The Saraswat Co - Op. Bank Ltd.
0
16 July 2014
The Saraswat Cooperative Bank Ltd
0
17 January 2011
Dbs Bank Ltd
0
04 January 2010
Citibank N. A.
0
23 November 2009
Standard Chartered Bank
0
27 August 2009
Standard Chartered Bank
0
17 July 2009
Standard Chartered Bank
0
13 March 2009
Idbi Bank Limited
0
23 January 2009
Citi Bank N.a.
0
10 February 2014
Idbi Bank Limited
0
19 December 2016
Others
0
14 December 2017
Others
0
10 July 2008
Hdfc Bank Limited
0
31 July 2008
Director Of Industries Himachal Pradesh Through General Manager District Industries
0
31 July 2008
Members Secretary Himachal Pradesh
0
28 November 2008
The Saraswat Cooperative Bank Ltd
0
28 November 2008
The Saraswat Cooperative Bank Ltd
0
30 January 2009
State Bank Of India
0
11 May 2012
Janakalyan Sahakari Bank Limited
0
29 May 2012
Dbs Bank Limited
0
14 March 2000
The Saraswat Co - Op Bank Ltd.
0
12 October 1965
The Saraswat Co - Op. Bank Ltd.
0
16 August 1973
The Saraswat Co - Op Bank Ltd.
0
10 September 1999
State Bank Of India
0
31 March 1979
The Mahrashrtra State Financial Corporation
0
10 February 1981
Canara Bank
0
06 May 1982
Canara Bank
0
23 February 1984
The Saraswat Co - Op Bank Ltd.
0
19 September 1986
The Saraswat Co - Op. Bank Ltd.
0
27 February 1989
The Saraswat Co - Op Bank Ltd.
0
17 December 1993
The Saraswat Co - Op Bank Ltd.
0
18 December 1993
The Saraswat Co - Op Bank Ltd.
0
27 August 1994
The Saraswat Co - Op Bank Ltd.
0
14 November 1994
The Saraswat Co - Op Bank Ltd.
0
01 March 1997
The Saraswat Co - Op Bank Ltd.
0
19 April 1999
The Saraswat Co - Op. Bank Ltd.
0
10 September 1999
State Bank Of India
0
26 July 2001
Export - Import Bank Of India
0
15 June 2004
Icici Bank Uk Ltd.
0
16 August 2023
Hdfc Bank Limited
0
06 January 2023
Others
0
30 May 2022
Hdfc Bank Limited
0
22 March 2022
Others
0
16 September 2016
Citi Bank N.a.
0
05 November 2020
Others
0
14 July 2015
Citi Bank N.a.
0
20 August 2021
Others
0
28 December 2016
Others
0
30 November 2018
Standard Chartered Bank
0
24 May 2019
Others
0
20 December 2019
Standard Chartered Bank
0
20 December 2019
Standard Chartered Bank
0
28 November 2008
Others
0
30 June 2008
Others
0
22 October 1965
The Saraswat Co - Op Bank Ltd.
0
07 November 1960
The Saraswat Co - Op Bank Ltd.
0
24 May 1963
The Saraswat Co - Op Bank Ltd.
0
26 May 1964
The Saraswat Co - Op Bank Ltd.
0
17 July 1967
The Saraswat Co - Op Bank Ltd.
0
27 September 1971
The Saraswat Co - Op Bank Ltd.
0
23 May 1980
The Saraswat Co - Op Bank Ltd.
0
28 May 1980
The Saraswat Co - Op Bank Ltd.
0
26 June 1982
The Saraswat Co - Op Bank Ltd.
0
04 April 1991
The Saraswat Co - Op Bank Ltd.
0
14 February 1996
The Saraswat Co - Op Bank Ltd.
0
31 July 1997
The Saraswat Co - Op Bank Ltd.
0
15 October 1998
The Saraswat Co - Op Bank Ltd.
0
10 May 2000
The Saraswat Co - Op. Bank Ltd.
0
26 August 2003
State Bank Of India
0
04 October 1997
The Saraswat Co - Op Bank Ltd.
0
01 March 1997
The Saraswat Co - Op. Bank Ltd.
0
29 June 1995
The Saraswat Co - Op Bank Ltd.
0
01 March 1997
The Saraswat Co-op Bank Ltd.
0
17 March 2006
Yes Bank Limited
0
27 October 2005
Bank Of India Limited
0
14 June 2001
The Saraswat Co - Op. Bank Ltd.
0
16 July 2014
The Saraswat Cooperative Bank Ltd
0
17 January 2011
Dbs Bank Ltd
0
04 January 2010
Citibank N. A.
0
23 November 2009
Standard Chartered Bank
0
27 August 2009
Standard Chartered Bank
0
17 July 2009
Standard Chartered Bank
0
13 March 2009
Idbi Bank Limited
0
23 January 2009
Citi Bank N.a.
0
10 February 2014
Idbi Bank Limited
0
19 December 2016
Others
0
14 December 2017
Others
0
10 July 2008
Hdfc Bank Limited
0
31 July 2008
Director Of Industries Himachal Pradesh Through General Manager District Industries
0
31 July 2008
Members Secretary Himachal Pradesh
0
28 November 2008
The Saraswat Cooperative Bank Ltd
0
28 November 2008
The Saraswat Cooperative Bank Ltd
0
30 January 2009
State Bank Of India
0
11 May 2012
Janakalyan Sahakari Bank Limited
0
29 May 2012
Dbs Bank Limited
0
14 March 2000
The Saraswat Co - Op Bank Ltd.
0
12 October 1965
The Saraswat Co - Op. Bank Ltd.
0
16 August 1973
The Saraswat Co - Op Bank Ltd.
0
10 September 1999
State Bank Of India
0
31 March 1979
The Mahrashrtra State Financial Corporation
0
10 February 1981
Canara Bank
0
06 May 1982
Canara Bank
0
23 February 1984
The Saraswat Co - Op Bank Ltd.
0
19 September 1986
The Saraswat Co - Op. Bank Ltd.
0
27 February 1989
The Saraswat Co - Op Bank Ltd.
0
17 December 1993
The Saraswat Co - Op Bank Ltd.
0
18 December 1993
The Saraswat Co - Op Bank Ltd.
0
27 August 1994
The Saraswat Co - Op Bank Ltd.
0
14 November 1994
The Saraswat Co - Op Bank Ltd.
0
01 March 1997
The Saraswat Co - Op Bank Ltd.
0
19 April 1999
The Saraswat Co - Op. Bank Ltd.
0
10 September 1999
State Bank Of India
0
26 July 2001
Export - Import Bank Of India
0
15 June 2004
Icici Bank Uk Ltd.
0
14 December 2023
Hdfc Bank Limited
0
16 August 2023
Hdfc Bank Limited
0
06 January 2023
Others
0
30 May 2022
Hdfc Bank Limited
0
22 March 2022
Others
0
16 September 2016
Citi Bank N.a.
0
14 July 2015
Citi Bank N.a.
0
05 November 2020
Others
0
20 August 2021
Others
0
30 June 2008
Others
0
28 November 2008
Others
0
28 December 2016
Others
0
24 May 2019
Others
0
20 December 2019
Standard Chartered Bank
0
20 December 2019
Standard Chartered Bank
0
22 October 1965
The Saraswat Co - Op Bank Ltd.
0
30 November 2018
Standard Chartered Bank
0
24 May 1963
The Saraswat Co - Op Bank Ltd.
0
26 May 1964
The Saraswat Co - Op Bank Ltd.
0
17 July 1967
The Saraswat Co - Op Bank Ltd.
0
27 September 1971
The Saraswat Co - Op Bank Ltd.
0
23 May 1980
The Saraswat Co - Op Bank Ltd.
0
28 May 1980
The Saraswat Co - Op Bank Ltd.
0
26 June 1982
The Saraswat Co - Op Bank Ltd.
0
04 April 1991
The Saraswat Co - Op Bank Ltd.
0
14 February 1996
The Saraswat Co - Op Bank Ltd.
0
31 July 1997
The Saraswat Co - Op Bank Ltd.
0
15 October 1998
The Saraswat Co - Op Bank Ltd.
0
10 May 2000
The Saraswat Co - Op. Bank Ltd.
0
07 November 1960
The Saraswat Co - Op Bank Ltd.
0
26 August 2003
State Bank Of India
0
04 October 1997
The Saraswat Co - Op Bank Ltd.
0
01 March 1997
The Saraswat Co - Op. Bank Ltd.
0
29 June 1995
The Saraswat Co - Op Bank Ltd.
0
01 March 1997
The Saraswat Co-op Bank Ltd.
0
17 March 2006
Yes Bank Limited
0
27 October 2005
Bank Of India Limited
0
14 June 2001
The Saraswat Co - Op. Bank Ltd.
0
16 July 2014
The Saraswat Cooperative Bank Ltd
0
17 January 2011
Dbs Bank Ltd
0
04 January 2010
Citibank N. A.
0
23 November 2009
Standard Chartered Bank
0
27 August 2009
Standard Chartered Bank
0
17 July 2009
Standard Chartered Bank
0
13 March 2009
Idbi Bank Limited
0
23 January 2009
Citi Bank N.a.
0
10 February 2014
Idbi Bank Limited
0
19 December 2016
Others
0
14 December 2017
Others
0
10 July 2008
Hdfc Bank Limited
0
31 July 2008
Director Of Industries Himachal Pradesh Through General Manager District Industries
0
31 July 2008
Members Secretary Himachal Pradesh
0
28 November 2008
The Saraswat Cooperative Bank Ltd
0
28 November 2008
The Saraswat Cooperative Bank Ltd
0
30 January 2009
State Bank Of India
0
11 May 2012
Janakalyan Sahakari Bank Limited
0
29 May 2012
Dbs Bank Limited
0
14 March 2000
The Saraswat Co - Op Bank Ltd.
0
12 October 1965
The Saraswat Co - Op. Bank Ltd.
0
16 August 1973
The Saraswat Co - Op Bank Ltd.
0
10 September 1999
State Bank Of India
0
31 March 1979
The Mahrashrtra State Financial Corporation
0
10 February 1981
Canara Bank
0
06 May 1982
Canara Bank
0
23 February 1984
The Saraswat Co - Op Bank Ltd.
0
19 September 1986
The Saraswat Co - Op. Bank Ltd.
0
27 February 1989
The Saraswat Co - Op Bank Ltd.
0
17 December 1993
The Saraswat Co - Op Bank Ltd.
0
18 December 1993
The Saraswat Co - Op Bank Ltd.
0
27 August 1994
The Saraswat Co - Op Bank Ltd.
0
14 November 1994
The Saraswat Co - Op Bank Ltd.
0
01 March 1997
The Saraswat Co - Op Bank Ltd.
0
19 April 1999
The Saraswat Co - Op. Bank Ltd.
0
10 September 1999
State Bank Of India
0
26 July 2001
Export - Import Bank Of India
0
15 June 2004
Icici Bank Uk Ltd.
0
Documents
Form MSME FORM I-01052024_signed
Optional Attachment-(1)-28032024
Form Addendum to AOC-4 CSR-28032024_signed
Form MSME FORM I-04122023_signed
List of share holders, debenture holders;-10112023
Optional Attachment-(1)-10112023
Optional Attachment-(3)-10112023
Optional Attachment-(2)-10112023
Copy of MGT-8-10112023
Form MGT-7-10112023_signed
Form MSME FORM I-27102023
Form MGT-15-21102023_signed
XBRL financial statements duly authenticated as per section 134 (including Board's report,auditor's report and other documents)-12102023
XBRL document in respect Consolidated financial statement-12102023
Optional Attachment-(1)-11102023
Form AOC-4(XBRL)-12102023_signed
Form BEN - 2-14092023_signed
Declaration under section 90-14092023
Form BEN - 2-04092023_signed
Form BEN - 2-03092023_signed
Form MSME FORM I-29082023_signed
Form BEN - 2-03082023_signed
Form BEN - 2-03082023
Declaration under section 90-03082023
Form MSME FORM I-28042023_signed
Copy of MGT-8-09112022
XBRL financial statements duly authenticated as per section 134 (including Board's report,auditor's report and other documents)-09112022
List of share holders, debenture holders;-09112022
Optional Attachment-(3)-09112022
Optional Attachment-(2)-09112022
